Rossari Biotech Ltd

Rossari Biotech Ltd

Next 500 2024
+ 3 More
+ 3 More
OVERVIEW
FINANCIALS
NEWS

Featured In Fortune India Ranking

Next 500 India
#339(2024)#240(2023)#387(2022)#474(2021)
#339(2024)#240(2023)#387(2022)#474(2021)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
1,902
(INR Cr)
Net Operating Income
1,831
(INR Cr)
Assets
1,171
(INR Cr)
Profit
131
(INR Cr)
Net Worth
1,048
(INR Cr)

Fortune India Coverage

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS20242023202220212020201920182017201620152014201320122011
Revenue
(INR Cr)
1902
13.5%
1675
10.4%
1517
108.7%
727
20.9%
601
12.8%
533
81.7%
293
25.1%
235
36.4%
172
16.2%
148
4.8%
141
24.1%
114
-4.6%
119
-2.3%
122
-
Net Operating Income
(INR Cr)
1831
10.55%
1656
11.66%
1483
109.06%
709
18.21%
600
16.25%
516
0.00%
292
25.03%
233
31.05%
178
15.91%
154
11.95%
137
25.37%
109
-7.13%
118
-3.14%
122
0.00%
Profit
(INR Cr)
131
21.8%
107
9.8%
98
21.8%
80
22.9%
65
42.8%
46
58.0%
29
85.5%
16
355.9%
3
-7.3%
4
1.9%
4
13.5%
3
-36.6%
5
-1.4%
5
-
Assets
(INR Cr)
1171
17.1%
999
10.9%
902
120.0%
410
15.4%
355
166.9%
133
16.5%
114
30.7%
87
30.1%
67
-19.0%
83
3.0%
81
3.1%
78
4.3%
75
8.1%
69
-
Net Worth
(INR Cr)
1048
14.5%
915
13.7%
805
97.0%
409
42.6%
287
131.6%
124
0.0%
90
47.7%
61
33.9%
45
7.5%
42
-3.1%
43
20.3%
36
8.1%
33
5.5%
32
0.0%
Employee Cost
(INR Cr)
103
4.6%
99
45.2%
68
61.8%
42
12.8%
37
35.2%
28
40.9%
20
38.2%
14
23.5%
11
6.3%
11
4.3%
10
46.2%
7
15.0%
6
34.4%
5
-
Interest Cost
(INR Cr)
19221334312345553
Cash & Bank Balance
(INR Cr)
301245288127612210100
Total Debt
(INR Cr)
11974806782224224137424138

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS20242023202220212020201920182017201620152014201320122011
Profit As % Of Revenues 6.9%6.4%6.4%11.0%10.9%8.6%9.9%6.7%2.0%2.5%2.6%2.8%4.2%4.2%
Profit As % Of Assets 11.2%10.7%10.8%19.6%18.4%34.3%25.3%17.8%5.1%4.5%4.5%4.1%6.7%7.4%
Profit As % Of Networth 12.5%11.7%12.1%19.6%22.8%36.9%32.3%25.7%7.6%8.8%8.3%8.8%15.1%16.1%
Interest Cost to EBITDA % 7.8%10.0%6.9%2.4%3.4%3.7%3.0%8.7%27.9%32.0%34.8%35.8%32.7%23.8%
Debt to Equity Ratio 0.110.080.01-0.230.060.240.400.490.970.851.161.241.19
RONW 13.3%12.5%16.1%23.0%31.8%36.9%38.5%29.5%7.8%8.6%9.1%9.2%15.1%16.1%
ROCE 18.2%17.5%22.7%28.7%37.4%49.8%40.4%27.0%11.0%11.0%11.1%10.4%15.1%12.8%